CAS No.: 915769-50-5
Dovitinib lactate hydrate Catalog No. CSN12885
Synonyms: TKI258 lactate hydrate;CHIR-258 lactate hydrate;TKI-258
Dovitinib lactate is the Lactate of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and HER2.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Huynh H, Chow PK, et al. Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma. J Hepatol. 2012 Mar;56(3):595-601.
- [2] Trudel S, Li ZH, et al. CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma. Blood. 2005 Apr 1;105(7):2941-8.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 915769-50-5 | 储存条件 |
|
|
| 分子式 | C24H29FN6O5 | 运输 | 蓝冰 | |
| 分子量 | 500.52 | 别名 | TKI258 lactate hydrate;CHIR-258 lactate hydrate;TKI-258;CHIR-258;Dovitinib lactate |
